spirogermanium has been researched along with carmustine in 2 studies
*Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) [MeSH]
*Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biegel, JA; Boggs, SS; Schwartz, GN | 1 |
| Kimler, BF | 1 |
2 other study(ies) available for spirogermanium and carmustine
| Article | Year |
|---|---|
A model to study drug effects on lymphoma and normal cell populations using the AKR/J mouse.
Topics: Animals; Carmustine; Cell Line; Disease Models, Animal; Germanium; Karyotyping; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred AKR; Neoplasm Transplantation; Organometallic Compounds; Spiro Compounds | 1982 |
The 9L rat brain tumor model for pre-clinical investigation of radiation-chemotherapy interactions.
Topics: Animals; Antineoplastic Agents; Aziridines; Benzoquinones; Bleomycin; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Radiation; Gliosarcoma; Male; Organometallic Compounds; Rats; Rats, Inbred F344; Spiro Compounds; Vincristine | 1994 |